This is a really exciting project for the industry. To reduce levels of Campylobacter, we need to take action throughout the supply chain.
Waltham, MA (PRWEB UK) 17 August 2015
Banham Poultry and Akeso Biomedical today announced a partnership focused on controlling Campylobacter infection of chickens. The partnership will seek to significantly reduce the levels of Campylobacter in chickens raised on the farm as part of an integrated approach.
The partnership will aim to develop a feed additive for poultry using Akeso’s Fe3C technology to reduce Campylobacter levels. The Fe3C technology was discovered at the University of Nottingham by Dr. Mahdavi, and Professors Soultanas and Ala’Aldeen, and prevents the binding of Campylobacter to the chicken’s GI tract and subsequent infection.
“We are delighted to partner with Banham Poultry to develop our Fe3C technology for the reduction of Campylobacter in poultry," said Dr. Simon Williams, CEO. “The Fe3C technology shows significant promise for the reduction of Campylobacter, and becoming an important component of an integrated approach.”
Initial trials with the feed additives began in April. In preliminary studies, TYPLEX™ and Q-PLEX™ feed additives both dramatically reduced infection levels in chicken. Furthermore, these additives also provided improvements in feed conversion ratio. Further studies are expected later in the year. As part of the development process it is anticipated that Banham Poultry will evaluate the feed additives in commercial trials.
Lars Brattinga, General Manager Agriculture at Banham Poultry, said: “This is a really exciting project for the industry. To reduce levels of Campylobacter, we need to take action throughout the supply chain. We still don’t know the source of Campylobacter, which is what makes it so difficult to control. This feed additive could give us the tool we need to combat this bug."
About Banham Poultry
Banham Poultry Ltd is an independent family business after (50) years and the largest employer in the mid Norfolk constituency. Banham produce fresh, quality chicken for retail (approx. 780,000 per week). Banham is an integrated poultry processor based in Norfolk with breeder (rearer and layer) farms, two hatcheries, broiler farms and processing facility.
For more information, please visit http://www.banhampoultryuk.com/
About Akeso Biomedical, Inc.
Akeso Biomedical, Inc. is developing new solutions for the treatment of bacterial infections and microbial biofilms using a proprietary broad-spectrum iron complex chemistry known as Fe3C. The Company’s product pipeline includes Fe3C compounds for the prevention of foodborne illnesses, and the treatment and prevention of other bacterial infections. For more information, please send inquiries to contact(at)akesobiomedical(dot)com.
Akeso Biomedical, Inc. is a VIC Technology Venture Development™ portfolio company.